Colonizing the heart from the epicardial side.
Data(s) |
30/04/2012
|
---|---|
Identificador |
http://www.ncbi.nlm.nih.gov/pubmed/22546531 scrt106 Stem Cell Res Ther, 2012, 3 (2), pp. 15 - ? http://hdl.handle.net/10161/8428 1757-6512 |
Relação |
Stem Cell Res Ther 10.1186/scrt106 |
Tipo |
Journal Article |
Cobertura |
England |
Resumo |
The clinical use of stem cells, such as bone marrow-derived and, more recently, resident cardiac stem cells, offers great promise for treatment of myocardial infarction and heart failure. The epicardium-derived cells have also attracted attention for their angiogenic paracrine actions and ability to differentiate into cardiomyocytes and vascular cells when activated during cardiac injury. In a recent study, Chong and colleagues have described a distinct population of epicardium-derived mesenchymal stem cells that reside in a perivascular niche of the heart and have a broad multilineage potential. Exploring the therapeutic capacity of these cells will be an exciting future endeavor. |
Formato |
15 - ? |
Idioma(s) |
ENG |
Palavras-Chave | #Animals #Bone Marrow Cells #Mesenchymal Stromal Cells #Myocytes, Cardiac #Pericardium |